Charles & Colvard manufactures, markets, and distributes Charles & Colvard Created Moissanite? (which the company refers to as moissanite or moissanite jewels) and finished jewelry featuring its proprietary moissanite gemstone for sale in the worldwide jewelry market. The company sells loose moissanite jewels and finished jewelry through various operating segments: its Online Channels segment, which comprises its charlesandcolvard.com website, e-commerce outlets, including marketplaces, drop-ship customers, and other e-commerce customers; and its Traditional segment, which consists of domestic and international distributors and retail customers.

Chiasma is a clinical-stage biopharmaceutical company focused on improving the lives of patients who face challenges related with their existing treatments for diseases. The company is evaluating oral octreotide capsules, conditionally trade-named MYCAPSSA, its sole Transient Permeability Enhancer platform-based clinical product candidate, in clinical trials in adult patients for the treatment of acromegaly to potentially support regulatory approval in the United States and European Union. The company is also conducting a clinical trial, referred to as MPOWERED, of oral octreotide capsules for the maintenance treatment of adult patients with acromegaly to support regulatory approval in the European Union.

Employers Holdings is a holding company. Through its wholly owned insurance subsidiaries, the company is engaged as a providers of workers' compensation insurance and services focused on select, small businesses engaged in low-to-medium hazard industries. The company provides insurance through Employers Insurance Company of Nevada, Employers Compensation Insurance Company, Employers Preferred Insurance Company, Employers Assurance Company and Cerity Insurance Company. Workers' compensation provides insurance coverage for the statutorily prescribed benefits that employers are required to provide to their employees who may be injured or suffer illness in the course of employment.

Pluristem Therapeutics is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company's product candidates include: PLX-PAD, which is in a multinational clinical trial in critical limb ischemia, and in a multinational clinical trial in recovery following surgery for hip fracture; PLX-R18, which is under development in the United States for acute radiation syndrome, as well as in a trial in the United States and Israel for incomplete hematopoietic recovery following hematopoietic cell transplantation; and PLX-Immune, which is under pre-clinical development for treatment of certain types of human cancer.

ServiceSource International is engaged in outsourced customer success and revenue growth solutions. The company's solutions span the lifecycle of its clients' customers, from landing new customers (Co. provides lead generation, inside sales, and outsourced sales operations services), adoption (Co. provides customer onboarding and customer success management services), expansion (Co. provides cross-sell and upsell, warranty conversion, account-based marketing and channel recruitment and enablement) and renewals (Co. provides renewals management services, including the sale of maintenance and support service contracts for the products used by its clients' end-users).

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.

State Auto Financial is a property and casualty insurance holding company. Through its subsidiaries, the company is engaged in writing personal and business insurance. The company's reportable insurance segments are personal insurance and commercial insurance. In its personal insurance segment, the company writes standard insurance covering personal exposures to individuals. The primary coverages provided are personal auto, homeowners, and other personal. In its commercial insurance segment, the company writes standard insurance covering small to medium sized commercial exposures. The company provides coverages including commercial auto, small commercial package, farm and ranch, workers' compensation and other commercial.